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Summary  
Regeneration of central nervous system (CNS) myelin involves differentiation of oligodendrocytes 
from oligodendrocyte progenitor cells (OPC). In multiple sclerosis (MS), remyelination can fail 
despite abundant OPC in lesions, suggesting impairment of oligodendrocyte differentiation. 
Various T cells are present in the CNS of MS patients yet the role of T cells in remyelination has 
received little attention. Here we report a new function of regulatory T cells (Treg) in promoting 
oligodendrocyte differentiation and (re)myelination. Treg-deficient mice exhibited significantly 
impaired remyelination and fewer differentiated oligodendrocytes that was rescued by adoptive 
transfer of Treg in vivo. In brain slice cultures, Treg accelerated developmental myelination and 
remyelination, even in the absence of overt inflammation. Treg directly promoted OPC 
differentiation in vitro and myelination in OPC-dorsal root ganglion neuron co-cultures. We 
identified CCN3 as a novel Treg-derived protein that was both necessary and sufficient for Treg-
induced oligodendrocyte differentiation and brain slice myelination in vitro. This is the first 
evidence of CCN3 in CNS regeneration and of CCN3 production by T cells. These findings point to a 
new regenerative function of Treg in the CNS, distinct from immunomodulation. Although 
originally named ‘Treg’ to reflect immunoregulatory roles, this name also aptly captures emerging 
regenerative functions of Treg. 
 
The failure to reinvest demyelinated axons with new myelin sheaths results in a lack of 
axonal conduction and metabolic support. This ultimately leads to irreversible axonal loss that 
typifies later stages of chronic demyelinating diseases such as MS, leaving patients with permanent 
neurological disability1,2. Remyelination frequently occurs in the context of innate and adaptive 
immune responses3,4. T cells can act as effectors of myelin damage but are also required for 
successful remyelination5. However, T cells encompass a range of phenotypically and functionally 
distinct subsets and contributions of T cell subsets to CNS remyelination are poorly understood. 
 3 
 
Since inflammation-resolving effects of Treg frequently coincide with tissue regeneration, we 
hypothesized that Treg promote remyelination. 
 
To study regenerative T cell functions in remyelination in vivo, distinct from classical T cell-
mediated demyelination observed in experimental autoimmune encephalomyelitis (EAE), focal 
demyelination was induced by injecting lysolecithin into spinal cord white matter of mice. Such 
lesions naturally remyelinate within one month and follow a well-defined time-course with distinct 
phases of OPC activation, recruitment and oligodendrocyte differentiation6,7. Flow cytometric 
immunophenotyping at 3 days post lesion (d.p.l.) demonstrated an abundance of CD45+CD11b+ 
myeloid cells in lesioned tissue as previously described8. However, distinct, albeit smaller 
populations of CD3+ and CD4+ T cells were also evident even up to 11 d.p.l.,  including 
CD3+CD4+Foxp3+ Treg, a T cell population recently implicated in tissue regeneration9,10 
(Supplementary Fig. 1a-e). To determine if Treg were functionally important in remyelination, we 
used Foxp3-DTR transgenic mice in which diphtheria toxin (DT) administration depletes Foxp3-
expressing cells11 (Supplementary Fig. 1f). Chronic DT exposure causes toxicity and considerable 
morbidity even in wild-type mice12-14 while Treg deficiency induces systemic immune activation11, 
precluding long-term studies. Therefore, densities of CC1+Olig2+ differentiated oligodendrocytes, as 
an established surrogate readout of remyelination15, were compared at 14 d.p.l. and electron 
microscopy was performed at 17 d.p.l.  
Treg-depleted animals exhibited significantly fewer differentiated CC1+Olig2+ 
oligodendrocytes than non-depleted animals or DT-treated wild-type controls (Fig. 1a,b). Mice 
lacking Treg exhibited comparable lesion sizes (Fig. 1c) indicating that Treg are not required to limit 
tissue damage in this model and crucially, that experimental groups had comparable burdens of 
demyelination to repair. Reduced numbers of CC1+Olig2+ cells in Treg-depleted mice could have 
arisen because of a failure to recruit sufficient OPC to the demyelinated area. However, no 
significant differences in Olig2+Ki67+ proliferating OPC at 5 d.p.l. or 10 d.p.l. were observed between 
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groups (Fig. 1d and Supplementary Fig. 1g) indicating that reduced generation of oligodendrocytes 
was likely due to impairment in differentiation. Restricting Treg depletion only to the pre-lesioning 
phase did not alter CC1+Olig2+ cell numbers (Supplementary Fig. 1h), suggesting that Treg are 
important in later stages of remyelination. Indeed electron microscopic analysis of lesions 
demonstrated significantly fewer remyelinated axons in Treg-depleted animals (Fig. 1e). To further 
test the role of Treg in remyelination using a gain-of-function model, MACS-purified wild-type Treg 
were injected into Treg-deficient animals (‘injected Treg’). Treg administration significantly increased 
numbers of CC1+Olig2+ differentiated oligodendrocytes in lesions, demonstrating the capacity of 
Treg to rescue impaired oligodendrocyte differentiation in vivo (Fig. 1f,g). To verify the importance 
of Treg in myelin regeneration in a second remyelinating model as well as at a different CNS site, 
demyelination was induced using cuprizone. Similar to results obtained using the spinal cord 
lysolecithin model, Treg depletion significantly impaired CC1+Olig2+ oligodendrocyte differentiation 
in the corpus callosum of cuprizone-treated mice at day 14 of the remyelination phase (Fig. 1h,i) but 
not at day 10 (Supplementary 1i). This finding was supported by reduced PLP mRNA expression in 
Treg-depleted animals at day 14 (Supplementary Fig. 1j). Treg depletion did not significantly affect 
overall oligodendrocyte lineage numbers (Supplementary Fig. 1k) emphasizing the predominant 
effect of Treg depletion on the differentiation phase of the regenerative response. These studies 
identify a novel role for Treg in the process of oligodendrocyte differentiation and CNS remyelination 
in both brain and spinal cord in vivo. 
 
Next, we asked if Treg exerted direct regenerative effects within CNS tissue distinct from 
immunomodulation of infiltrating immune cells. To this end, we used neonatal murine organotypic 
brain slice cultures which naturally generate compact myelin ex vivo via OPC proliferation, 
differentiation and axonal ensheathment16-19. To determine if Treg influence myelination, FACS-
purified CD4+Foxp3-eGFP+ natural Treg or control CD4+Foxp3- conventional T cells (Tconv) were 
added directly onto slices. T cells infiltrated tissues and GFP+ Treg were still detectable within slices 
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after 3 days in vitro (d.i.v.) (Supplementary Fig. 2a). Slices co-cultured with Treg cells contained 
significantly more MBP+ oligodendrocytes and had significantly higher myelination index (myelin and 
axonal overlap, representing axonal ensheathment by myelin) at 3 d.i.v. than control slices without 
cells (Supplementary Fig. 2b-d) or slices with Tconv cells (Supplementary Fig. 2e). These findings 
demonstrate a myelinating action induced specifically by Treg, rather than by activated T cells in 
general. 
To investigate mechanisms of Treg-induced myelination beyond cell-cell contact, slices were 
supplemented with conditioned media from CD4+ T cells that were either polarized to a Treg 
phenotype or were non-polarized (NP) to serve as activated T cell controls (Supplementary Fig. 2f), 
or control medium. Treg-conditioned media significantly increased MBP+ mature oligodendrocytes 
and myelination compared to controls (Fig. 2a-c, Supplementary Fig. 2g). These findings indicated 
that secreted factors drive oligodendrocyte differentiation and pro-myelinating effects of Treg. 
To test if Treg also promoted regeneration of myelin, slices myelinated in culture for 14 days 
and were then demyelinated with lysolecithin. Addition of Treg-conditioned media for 7 days 
following demyelination significantly increased MBP+ mature oligodendrocytes (Fig. 2d,f) and 
myelination index (Fig. 2e,f Supplementary movies) compared to controls. These increases 
represented an acceleration of remyelination by Treg as control slices eventually remyelinated after 
2 weeks (data not shown). This was confirmed by electron microscopy showing significantly 
increased numbers of remyelinated axons in Treg-treated slices compared to control, remyelinating 
slices (Supplementary Fig. 2h-j).  
Although brain slices lack peripheral immune cells, CNS-resident microglia and astrocytes 
can generate local inflammatory responses upon slicing and demyelination20,21 and therefore, effects 
of Treg on (re)myelination could be due to known anti-inflammatory functions. Thus, to categorically 
test if Treg directly promoted CNS myelination rather than indirectly via immunoregulation, slices 
were equilibrated for one week after slicing20 to allow pro-inflammatory cytokine production to 
subside (Supplementary Fig. 2k) prior to addition of T cell-conditioned media. In this model, slices 
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treated with Treg-conditioned media again exhibited significantly higher MBP+ oligodendrocyte 
numbers (Fig. 2g,i) and myelination index (Fig. 2h,i) than controls. These findings show that Treg 
directly promote oligodendrocyte differentiation and myelin production under minimal-
inflammatory conditions, suggesting a primary regenerative function of Treg in the CNS distinct 
from, but complementary to, known immunomodulatory functions. 
 
To further investigate mechanisms of Treg-induced remyelination via OPC differentiation we 
next determined whether Treg directly influenced glial cells using mixed glial cultures containing OPC 
as well as astrocytes and microglia (Supplementary Fig. 3a). Treg-conditioned media significantly 
increased oligodendrocyte differentiation compared to control medium (Fig. 3a,b,d) and control 
non-polarized T cell-conditioned medium (Supplementary Fig. 3b,c), demonstrating direct Treg 
signaling to glia. This effect was consistent independent of whether Tregs were induced from total 
CD4+ T cells or from naïve CD4+ T cells (Supplementary Fig. 3d). Supporting our in vivo findings, we 
observed no difference in oligodendrocyte lineage cell numbers (Fig. 3c), proliferation (Fig. 3e,f) or 
survival (Supplementary Fig. 3e,f). 
As proof of principle that Treg can directly modulate a regenerative cell population, 
independent of other CNS cells, pure OPC were cultured in the presence or absence of T cell-
conditioned media. Within just two days, OPC treated with Treg-conditioned media exhibited 
significantly more MBP+ differentiated oligodendrocytes (Fig. 3g,h) demonstrating a direct action of 
Treg on OPC. To test if this was functionally relevant, Treg-conditioned media were added to OPC-
dorsal root ganglion (DRG) neuron co-cultures. Treg accelerated myelination of DRG neurons, 
evident within 4 days of stimulation with Treg-conditioned media (Fig. 3i,j). Although not ruling out 
additional indirect mechanisms, these findings show that Treg-secreted factors can directly signal to 
OPC to promote oligodendrocyte differentiation and functional myelination. This demonstrates for 
the first time that Treg can alter the regenerative capacity of CNS progenitor cells. 
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We next investigated Treg-secreted factors that enhanced oligodendrocyte differentiation 
and myelination. Analysis of conditioned media by proteome profiling identified a number of 
candidate factors relevant to regeneration (Supplementary Fig. 4a) including CCN3 a growth 
regulatory protein with bioactivity in extracellular, cytoplasmic and nuclear compartments and 
implicated in regeneration of various tissues22-25. Dual ELISA and western blot validation confirmed 
that CCN3 was produced by Treg (Fig. 4a,b). To determine if CCN3 mediated the oligodendrocyte-
differentiating effect of Treg, CCN3 antibody was added to glial and brain slice cultures treated with 
Treg-conditioned media. Anti-CCN3 antibody abolished Treg-induced oligodendrocyte differentiation 
in glial cultures (Fig. 4c,d, Supplementary Fig. 4b) and inhibited the pro-myelinating effect of Treg in 
brain slice cultures (Fig. 4e). To confirm these findings with a second loss-of-function approach, 
CCN3 was depleted from Treg-conditioned media (Supplementary Fig. 4c, d) and recovered as eluted 
protein. Treg-conditioned media depleted of CCN3 failed to promote oligodendrocyte differentiation 
in glial cultures (Fig. 4f) or brain slice myelination (Fig. 4g,h). Furthermore, treatment with recovered 
CCN3 significantly enhanced brain slice myelination (Fig. 4g,h). These studies implicate CCN3 as a 
novel Treg-derived protein that mediates Treg-driven OPC differentiation and CNS myelination. 
 
Immune-mediated tissue regeneration is an expanding field and recent studies highlight the 
importance of innate immune signaling in myelin regeneration3,4,26. Yet, despite decades of research 
into T cell-mediated pathogenesis and immunomodulation of CNS demyelination, very little is known 
about T cell functions in remyelination. Given that T cell-targeting therapies are used in MS, it is 
crucial to understand the full range of roles played by T cells. However, when interrogating 
immunoregenerative functions, appropriate choice of experimental models is crucial. Treg limit 
damage in many inflammatory disease models including EAE. Overlapping tissue damage and 
regeneration often occur in immune-mediated disease models such as EAE. Thus, true enhancement 
of regeneration can be challenging to distinguish from modulation of immunopathogenicity in these 
models. This motivated our choice of lysolecithin-induced demyelination in which the demyelinating 
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insult is time-limited, clearly defined anatomically, independent of immune-driven tissue damage 
and follows a well-defined course of highly efficient myelin regeneration. With this approach, in 
combination with other models without peripheral immune influence such as OPC and brain slice 
cultures, we have uncovered a key regenerative function of Treg. Mechanisms underlying this 
function include acceleration of oligodendrocyte differentiation and (re)myelination, via CCN3, a 
protein not previously known to target OPC, or indeed, to be produced by Treg. 
CCN3 is a growth regulatory protein with bioactivity in extracellular, cytoplasmic and nuclear 
compartments and implicated in regeneration of various tissues23-25,27,28. CCN3 is expressed in the 
developing CNS22,29 and glioma30, but has not previously been implicated in CNS regeneration. Of 
note, we detected CCN3 expression in early organotypic brain slice cultures (data not shown) which 
may be developmentally regulated or due to tissue injury. In immune development, CD34+ bone 
marrow progenitor cells express CCN3; however, ours is the first report that Treg, or indeed any 
T cell population, produces CCN3. Together, these findings identify CCN3 as an immune effector 
molecule from early innate immune development to resolution of adaptive immune responses. This 
potentially places CCN3 at the leading edge of immune-mediated tissue regeneration and warrants 
investigation in immune cells at other anatomical sites. Interestingly, commercially sourced 
recombinant CCN3 did not induce oligodendrocyte differentiation (data not shown). This may be due 
to the lack of critical post-translational modifications in recombinant CCN3 and/or the presence of 
a 10-His tag at the C-terminus of the recombinant protein. This tag may impair bioactivity of 
this key functional region of CCN3, which contains a cysteine knot motif involved in homo- 
and heterodimerization. This emphasizes the importance of both gain-of-function and loss-of-
function studies of CCN3 in reductionist and more complex models.  
Recently Burzyn et al. identified roles for Treg in muscle regeneration associated with local 
immunomodulation and amphiregulin expression9 while Arpaia et al. reported TCR-independent 
tissue protective functions of amphiregulin-expressing Treg in influenza-infected lungs10. Other 
studies described associations of Treg with regeneration of cardiac muscle and neurons31-33. Here, 
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we identified that Treg directly promote oligodendrocyte differentiation and myelin production even 
in the absence of overt inflammation. Thus, signaling from Treg can directly increase the 
regenerative capacity of a progenitor cell population, independent of immunomodulation known to 
support regeneration at other anatomical sites.  This confers a primary regenerative role for Treg 
complementary to, but distinct from, known immunomodulatory functions. In concert, these two 
functions confer fundamental damage-limiting and damage-resolving roles to Treg. Therapies to 
boost tissue regeneration should consider this emerging and central role of Treg in natural 
regeneration. This knowledge holds therapeutic potential for tissue regeneration in diseases such as 
MS.  
Collectively, our novel findings and recent studies by others show that Treg promote 
regeneration via different factors in different tissues. Our regenerative immunology study expands 
the classical functions of T-reg beyond reg-ulation to reg-eneration.  
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Online methods 
Animals 
All mice were on a C57BL/6 background and were bred in-house. Foxp3-DTR mice were a kind gift 
from Prof. Alexander Rudensky (Memorial Sloan Kettering Institute, New York) and Foxp3-eGFP mice 
were a kind gift from Prof. B. Malissen34. Experiments used both male and female neonatal P0-P9 
pups and animals from 6-16 weeks from sources above. To deplete Foxp3+ cells in Foxp3-DTR mice, 
diphtheria toxin was administered as described below. All animal maintenance and experiments 
were in compliance with the UK Home Office and approved by the University’s Ethical Committee. 
 
Treg depletion and induction of lysolecithin-mediated demyelination 
To deplete Foxp3+ cells in Foxp3-DTR mice 1 µg DT in 200 µl saline was injected i.p. daily for 3-4 days 
before demyelination. For maintenance of Treg depletion, 1 µg DT was injected i.p. every 3rd day 
after the demyelination procedure. Control mice were treated with saline. Depletion was routinely 
confirmed in blood and spleen by flow cytometry. L-α-Lysophosphatidylcholine (lysolecithin) was 
used to induce a focal demyelinated lesion in the spinal cord of mice as described previously6,35. In 
brief, 1.2 Pl lysolecithin (Sigma) was injected into the ventral white matter of the lower thoracic 
spinal cord between vertebrae T11-12 or T12-13. At indicated time points, mice were terminally 
anesthetized with Ketamin/Rompun, transcardially perfused with 4% paraformaldehyde in PBS or 
PBS alone (for flow cytometry studies), and spinal cord tissue was dissected. 
 
Adoptive transfer of wild-type Treg into Treg-depleted FoxP3-DTR mice 
FoxP3-DTR mice were treated with DT as described above. In the 24 hr prior to lysolecithin-induced 
demyelination, mice were injected i.p. with 1x106 MACS-purified Treg from wild-type mice that were 
insensitive to DT treatment. 
 
Tissue processing  
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For immunohistochemistry, spinal cord tissue was post-fixed for 2-4 hr in 4% PFA and immersed in 
20% sucrose in PBS solution overnight. For cryo-preservation spinal cords were embedded with OCT 
medium (VWR) and non-consecutive 12 µm thick cryo-sections from the approximate center of 
lesions were mounted on glass slides4. 
 
Immunofluorescence staining of CNS tissue 
After blocking with 10% goat serum, spinal cord sections were incubated with antibodies for APC 
(1:100, clone CC1, Abcam), Ki67 (1:200, clone SoIA15, eBioscience), and Olig2 (1:200; cat. no. 
AB9610, Millipore) overnight. Secondary antibodies goat anti-rabbit AF488 (1:200; cat. no. A-11008, 
Life Technologies) and goat anti-rat AF594 (1:200; cat. no. A-11007, Life Technologies) were 
incubated for 1 hr at RT. For CC1 detection acidic antigen retrieval was performed and a mouse-on-
mouse immunodetection kit was used (Vector Laboratories). Nuclei were counterstained with DAPI 
before coverslipping with ProLong Gold Antifade (Life Technologies). Spinal cord images were 
acquired on a Leica DM5500 epifluorescence microscope. 
 
Luxol Fast Blue staining of spinal cord tissue 
Tissue was placed in 1:1 alcohol:chloroform solution for 10 hr before dehydration in alcohol and 
incubation in 0.1% luxol fast blue solution (Sigma) at 56°C for 16 hr. Tissue was rinsed and 
differentiated in 0.05% lithium carbonate solution for 30 sec followed by 70% alcohol for 30 sec. 
After washing with distilled water tissue was differentiated in 95% alcohol and twice in 100% alcohol 
(each 5 min) before immersing twice in xylene for 5 min and coverslipping. 
 
Electron Microscopy of spinal cord lesions 
Animals were perfused with 3% glutaraldehyde, 2% paraformaldehyde, 0.1M phosphate buffer (pH 
7.4), 0.7% (w/v) NaCl and spinal cords were dissected and post-fixed overnight. Specimen were post-
fixed in 1% osmium tetraoxide (Agar Scientific, Stansted, UK), dehydrated, stained en bloc with 
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uranyl acetate (Agar Scientific, Stansted, UK), and embedded in Durcupan resin (Sigma-Aldrich, UK). 
Ultrathin sections (70 nm) were cut on a Leica UCT ultramicrotome with a Diamond knife (Diatome), 
mounted on formvar-coated copper grids (Electron Microscopy Science), and counterstained with 
uranyl acetate and lead citrate. Random electron micrographs (35 per animal) were taken from the 
lesions with a FEI Spirit transmission microscope with a Gatan Orius SC200B Camera. A total of 3399 
control axons and 2076 axons from Treg-depleted lesions were analysed blindly. 
 
Flow cytometric immunophenotyping 
Fresh spinal cord tissue was dissected following transcardial perfusion with PBS was weighed and 
placed in Neuro Medium (Miltenyi Biotec). Medium was removed and tissues were individually 
passed through 70 µm strainers, washed with 30% percoll to pellet cells and myelin-containing 
supernatant was carefully removed. Cells were resuspended in 200 µl flow cytometry staining buffer 
(FCSB; 1% FCS, 0.01% NaN3 in PBS) prior to cell surface staining with antibodies to CD45 (clone 104), 
CD11b (clone M1/70), CD3 (clone 145-2C11) and CD4 (clone GK1.5). Foxp3 expression was 
determined in fresh cells from Foxp3-eGFP or Foxp3-GFP-DTR mice. To calculate cell numbers, 
singlets were identified by FSC-H vs FSC-A,  and CD45+ cells were gated for subsequent analyses of 
CD11b, CD3, CD4 and Foxp3-eGFP. All flow cytometry antibodies were from eBioscience. Data were 
acquired on a FACSCanto II and analyzed using FlowJo software. 
 
Cuprizone-induced demyelination 
Eleven-week-old male C57BL/6 and FoxP3DTR mice were fed with 0.2% cuprizone 
[bis(cyclohexanone) oxaldihydrazone,  (Teklad Costum Diet TD.140804, Envigo]. Food and water 
were available ad libitum. Cuprizone feeding was maintained for 25 days to induce demyelination. 
Diet was then changed to normal rodent chow for additional 2 weeks to allow remyelination to 
occur. To deplete Treg, mice were injected with DT (0.04g DT/Kg) or vehicle on day 24 and day 25. 
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Treg depletion was maintained by DT administration every three days. Mice were sacrificed on day 
39 and were perfused transcardially with PBS followed by cold 4% paraformaldehyde. Brains were 
removed, postfixed overnight in 4% paraformaldehyde and cryoprotected in 30% sucrose. Coronal 
frozen sections of 20 µm thickness were  cut using a Leica cryostat. Sections between 1 mm and -1 
mm relative to Bregma were collected and stained for CC1 and Olig2 as described above. The 
number of mature oligodendrocytes in the corpus callosum was quantified on images of 1-2 sections 
per animal with five animals per group. Images of the midline segment of the corpus callosum from 
frontal and middle sections were used to delineate the area for analysis of Olig2/CC1 positive cells. 
 
Black Gold II staining 
Tissue sections were stained with Black Gold II  (AG105, Millipore Corp, Billerica, MA) according to 
manufacturer’s instructions. Briefly,  sections were washed in water, immersed in pre-warmed Black 
Gold II solution and incubated at 60°C for 15 min  followed by transfer into pre-warmed 1% sodium 
thiosulfate at  60°C  for 5 min. Slides were rinsed three times, dehydrated, immersed in xylene for 2 
min and coverslipped with  mounting media.  
 
Gene expression analyses 
For qPCR, total RNA was extracted from the cerebella of perfused mice with an RNeasy FFPE kit 
(Qiagen) using a modified protocol. Tissue was homogenised in supplied PKD buffer before 
treatment with proteinase K. All subsequent steps were followed according to manufacturer’s 
instructions. RNA purity and concentration was assessed by Nanodrop spectrophotometry. Samples 
were treated with DNase I (Invitrogen) prior to reverse transcription with Superscript IV (Invitrogen). 
cDNA samples were assayed in triplicate by qPCR using Fast SYBR Green (ThermoFisher Scientific) on 
a Roche LightCycler 480 system. Relative gene expression of plp1 gene was determined with the 
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Pfaffl method using gapdh as internal control36 . Primer sequences were as previously described37. 
An unpaired, two-tailed Student’s t test was performed to assess statistical differences on delta Ct 
values of each condition, with a significance threshold of 0.05. 
In situ hybridization of proteolipid protein (PLP) on paraformaldehyde-fixed CNS tissue was 
performed as previously described38.  The plasmid containing a fragment of 801bp plp cDNA was 
provided by Prof I Griffith (University of Glasgow). Briefly, sections were incubated with digoxigenin-
labeled complementary RNA probes at 65°C overnight and subjected to a standard wash protocol 
(50% formamide, 1× standard saline citrate, 0.1% Tween-20, 65°C, 3× 30 minutes) to remove 
nonspecific probe binding. The target bound probes were detected by alkaline phosphatase–
conjugated antidigoxigenin antibody, and visualized as purple precipitate after incubation in 
NBT/BCIP solution according to the manufacturer's instructions (Roche, Lewes, UK). The slides were 
dehydrated with ascending concentration of ethanol, cleared with xylene, and mounted in dibutyl 
phthalate in xylene. Images were acquired with the Zeiss Axio Observer microscope. 
 
T cell culture 
CD4+ T cells were immunomagnetically purified by negative selection (Stem Cell Technologies) from 
splenocytes of 6-10 week old female C57BL/6 mice and cultured in RPMI 1640 (Life Technologies) 
supplemented with 10% FCS, 1% penicillin/streptomycin, 1% L-glutamine, 1% Hepes, 1% sodium 
pyruvate, 1% non-essential amino acids and 50 nM β-mercaptoethanol. In Supplementary Fig 3d, 
naïve CD4+ T cells were purified using EasySep™ Mouse Naïve CD4+ T Cell Isolation Kits (Stem Cell 
Technologies). T cells were activated with plate bound anti-CD3 (1 µg/ml, clone 145-2C11) and 
soluble anti-CD28 (1 µg/ml, clone 37.51) (both eBioscience) for 3 days in non-polarizing (NP; no 
exogenous cytokine) or Treg-polarizing conditions consisting of rhTGF-β (2 ng/ml, R&D Systems), 
rhIL-2 (10 ng/ml, eBioscience) and anti-IFN-γ (10 µg/ml, clone XMG1.2, Bioxcell). T cells were then 
reactivated in brain slice medium (described below) for a further 72 hr and conditioned media were 
harvested. Polarization of all cultures was verified by flow cytometry and Treg cultures used for 
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experiments generally consisted of 80-90% Foxp3+ T cells (see Supplementary Fig. 2 f). For CCN3 
immunoblotting, depletion and elution, cells were reactivated in serum-free X-VIVO15 medium 
(Lonza). 
For adoptive transfer experiments, nTreg were immunomagnetically purified (Stem Cell 
Technologies) by negative selection of CD4+ T cells followed by positive selection of CD25+ cells from 
splenocytes and lymph nodes of C57BL/6 mice. For i.p. injection cells were resuspended at 
5x106 cells/ml in saline. 
 
Organotypic brain slice culture 
Brain stem slices (300 µm) from P0-2 C57BL/6 pups were prepared using a Mcllwain Tissue Chopper 
and cultured in transwell inserts with brain slice medium consisting of 46.6% minimum essential 
medium, 25% Earle’s balanced salt solution, 25% heat inactivated horse serum, 1% 
penicillin/streptomycin, 1% glutamax (Life Technologies) and 1.4% D-glucose (Sigma). Where 
indicated, slices were treated with 5% T cell-conditioned media and/or anti-CCN3 (10 µg/ml; clone 
231216, R&D Systems) and/or isotype control (clone 54447, R&D Systems) every other day. For 
remyelination studies, brain stem slices were demyelinated after 14 days in culture with lysolecithin 
(0.5 mg/ml, Sigma) for 16 hr. Slices were washed and allowed to remyelinate for up to 14 days. For 
co-culture studies, 1.7x104 FACS-purified natural Treg from Foxp3-eGFP mice were added directly on 
to brain stem slices in a volume of 10 μl (Supplementary Fig. 2 a). 
 
Staining of organotypic brain slices 
Slices were fluorescently stained for myelin basic protein (MBP; 1:600, clone 12, Millipore) and 
axonal neurofilament-200 (NF200; 1:200, clone RT97, Millipore). After fixation in 4% 
paraformaldehyde for 45 min at RT, slices were blocked and permeabilized at RT for 1 hr in 3% heat-
inactivated horse serum (Life Technologies), 2% bovine serum albumin (Sigma) and 0.5% Triton X-
100 (Sigma). Both primary and secondary antibodies (goat anti-rat AF594, cat. no. A11007, goat anti-
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mouse AF488 cat # A11001 and goat anti-mouse AF405 cat # A31553, 1:500; Life Technologies) were 
incubated overnight at 4oC. Slices were mounted with ProLong Gold Antifade (Life Technologies) and 
imaged with a Leica TCS SP5 confocal microscope at 0.5 µm intervals over 10 µm, taking up to 5 
fields of view (FOV) per slice, dependent on slice size. Representative images were displayed with a 
green look up table (LUT) for NF200 and red LUT for MBP, applied using Leica AF software. 
 
Electron microscopy of organotypic brain slices 
Slices were immersion fixed in 4%PFA/2% glutaraldehyde in 0.1M phosphate buffer for 24 hr, 
washed in phosphate buffer and post-fixed in 1% osmium tetroxide in 0.1 M phosphate buffer for 
45 min. Samples were dehydrated in increasing concentrations of acetone and embedded in Araldite 
resin.  Ultrathin 60 nm sections were stained in uranyl acetate and lead citrate and then viewed in a 
JEM1400 Transmission electron microscope (JEOL).  To count the percentage of myelinated fibres 
per unit area of slice (at least 600 µm2/condition), three photographs were taken from random, non-
overlapping fields from each of 3 slices per condition and analysed. To measure g-ratios, at least 35 
randomly chosen axons from each of 3 slices per condition were analysed by tracing the axonal 
circumference and the whole fibre circumference (using a graphics pad and pen). G-ratios were 
calculated by dividing these values and data were analysed using one-way ANOVA with 
Bonferroni  post-test with p < 0.05 considered significant. 
 
Mixed glial cultures 
Mixed glial cells were generated from P2-7 C57BL/6 pups according to the protocol of the Neural 
Tissue Dissociation Kit (P) (Miltenyi Biotec). In short, brains were dissected, cerebellum and 
meninges were removed and tissue was dissociated via mechanical and papain enzyme digestion 
prior to filtration through a 40 μm strainer. Cells were plated in poly-L-lysine-coated (10 μg/ml, 
Sigma) 96 well flat, glass-bottomed plates (BD Falcon) at a density of 105 cells per well and cultures 
were maintained at 37˚C, 5% CO2. Cells were cultured for 5 days in DMEM (Life Technologies) 
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supplemented with PDGFαα (10 ng/ml; PeproTech), 10% endotoxin-free FCS, 
1% penicillin/streptomycin and 1% L-glutamine (Life Technologies). Cells were cultured for a further 
2 days in neural medium (Miltenyi Biotec) supplemented with 1% penicillin/streptomycin, 1% L-
glutamine, 2% B27/MACS Neuro Brew21 (Miltenyi Biotec) and PDGFαα (10 ng/ml; PeproTech). At 
day 7 in culture, PDGFαα was withdrawn to allow oligodendrocyte differentiation and cells were 
stimulated with 5% Treg-conditioned media, rCCN3, anti-CCN3 (clone 231216) or isotype control 
(clone 54447) (all R&D Systems) or controls for up to 5 days. 
 
Immunofluorescence staining of mixed glial cultures  
Cell cultures were fixed in 4% paraformaldehyde (pH 7.4) for 15-20 min at RT and blocked in 10% 
normal goat serum with 0.1% Triton-X-100 for 1 hr. Cells were then incubated with primary antibody 
overnight at 4˚C and in secondary antibodies for 1 hr at RT. Cells were counterstained with DAPI for 
5 min at RT. Primary antibodies used were rabbit anti-mouse Olig2 (1:200; cat. no. AB9610, 
Millipore), rat anti-mouse MBP (1:200; clone 12, Millipore), rat anti-mouse Ki67 (1:200; clone 
SoIA15, eBioscience), rabbit anti-mouse GFAP (1:200; cat. no. Z0334, Dako) and rat anti-mouse 
CD11b (1:200; clone M1/70, eBioscience) and secondary antibodies used were goat anti-rabbit 
AF488 (1:1000; cat. no. A-11008) and goat anti-rat AF594 (1:1000; cat. no. A-11007; both Life 
Technologies). For live/dead staining unfixed cells were stained using the LIVE/DEAD® 
Viability/Cytotoxicity Kit for mammalian cells (Life Technologies). Immunofluorescence was detected 
using an EVOS microscope at 10X magnification and n=6 wells per condition with one mean value 
from multiple images calculated for each well. 
 
OPC purification 
Immunopanning purification of OPC was performed as previously described39. Briefly, OPC were 
purified from P7–9 mouse brain cortices. Tissue culture dishes were incubated overnight with goat 
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IgG and IgM secondary antibodies to mouse (cat. no. 115-005-004, Jackson Laboratories) in 50 mM 
Tris-HCl at a final concentration of 10 μg/ml, pH 9.5. Dishes were rinsed and incubated at room 
temperature (RT) with primary antibodies for Ran-2, GalC and O4 from hybridoma supernatants39. 
Rodent brain hemispheres were diced and dissociated with papain (Worthington) at 37°C. After 
trituration, cells were resuspended in a panning buffer (0.2% BSA in DPBS) and incubated at RT 
sequentially on three immunopanning dishes: Ran-2 and GalC were used for negative selection 
before positive selection with O4. OPC were released from the final panning dish using 0.05% 
Trypsin (Invitrogen). OPCs were typically 95% pure after immunopanning, with a viability of 94%. 
 
OPC–DRG co-cultures 
OPC-DRG co-cultures were prepared as previously described39. Briefly, DRG neurons from E15 
Sprague-Dawley rats were dissociated, plated (150,000 cells per 25 mm cover glass) and purified on 
collagen-coated coverslips in the presence of 100 ng/ml NGF (AbD Serotec). Neurons were 
maintained for 3 weeks and washed with DMEM (Invitrogen) extensively to remove any residual 
NGF before seeding OPC. Co-cultures were grown in chemically defined medium composed of 
DMEM (Invitrogen) supplemented with B27 (Invitrogen), N2 (Invitrogen), penicillin-streptomycin 
(Invitrogen), N-acetyl-cysteine (Sigma-Aldrich) and forskolin (Sigma-Aldrich). 
 
CCN3 quantification and depletion 
Proteome profiling of conditioned media was performed using an Angiogenesis Antibody Array (R&D 
Systems) as per manufacturer’s instructions, which identified CCN3 as a candidate protein of 
interest. Levels of CCN3 in T cell-conditioned media were quantified by ELISA (R&D Systems) 
according to manufacturer’s instructions. 
Treg-conditioned media were depleted of CCN3 using monoclonal anti-CCN3 antibody-coupled 
magnetic beads (clone 231216, R&D Systems and Thermo Scientific) or isotype control-coupled 
beads (clone 54447). Coupling of antibody and beads was performed according to manufacturer’s 
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instructions. In short, 1 mg of beads was incubated with 500 µg/mL of antibody solution and the 
flow-through was analysed by spectrophotometry. For immunoprecipitation, up to 1 ml of Treg-
conditioned media were added to 1 mg of monoclonal antibody-coupled magnetic beads and 
incubated on a rotator at RT for 2 hr with additional vortexing of the samples every 15 min to ensure 
that the beads remained in suspension. The samples were then placed in a magnetic stand and 
CCN3-depleted Treg-conditioned media and isotype-treated controls were collected. To elute Treg-
derived CCN3, beads were washed and elution buffer (0.1 M glycine, pH 2.0) was added for 3-5 min 
at RT. To neutralize the low pH of the solution, neutralization buffer (1 M Tris, pH 7.4) was 
immediately added, samples were placed on a magnetic stand, and the eluate containing Treg-
derived CCN3 was collected and resuspended in medium according to initial volume.  
 
Immunoblotting of CCN3 
T cell-conditioned media or recombinant CCN3 (R&D Systems) were enriched for CCN3 using 
heparin-sepharose beads as previously described40. In short, up to 10 ml of Treg-conditioned media 
(equivalent to 25 ng of CCN3), or recombinant CCN3 were added to 100 µl 50% heparin-sepharose 
slurry and incubated on a rotator at 4°C overnight. 50 µl of PBS-washed CCN3-bound heparin-
sepharose beads and 12.5 µl 5x reducing loading dye were boiled for 10 min prior to loading on a 
reducing 15% SDS-PAGE. Following transfer onto PVDF membrane (Millipore) and blocking (3% BSA 
in PBS/1% Tween) for 1 hr at RT, protein was probed using polyclonal anti-CCN3 antibody (1:1000; 
cat. no. AF1976, R&D Systems) overnight at 4oC and secondary anti-goat HRP (1:3000; cat. no. sc-
2020, Santa Cruz) for 1 hr at RT. 
 
Image analysis and data processing  
Customized ImageJ41 plugins were used to assist quantifying positively stained cells and areas in all 
models.  
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Regions of interest corresponding to spinal cord lesions were initially drawn using the polygon tool. 
Regions were subsequently refined based on the local cell density by thresholding a Gaussian-
smoothed duplicate of the DAPI channel to give a more detailed contour which was corrected 
manually if necessary using a brush selection tool. Cells were then counted manually within the 
lesion; in some cases counts were automatically initialized as localized regions of high fluorescence 
detected by the ‘find maxima’ command of ImageJ before manual verification and correction to 
ensure that all regions contributing to the final counts were consistent with expected cell 
morphology (i.e. no artefacts). ImageJ plugins were written to perform the lesion refinement and to 
assist with manual cell counting. 
Myelination index was used for overlap of myelin and axonal markers in 3D, indicating 
(re)myelination. Confocal z-stacks of brain slices, both red (MBP) and green (NF200) channels were 
pre-processed by first smoothing with a 3D isotropic Gaussian filter (sigma = 0.5 µm) before 
subtracting a background estimate created by applying a 3D morphological opening (filter 
radius = 1 µm). The processed channels were then thresholded, where the threshold was 
determined automatically by implementation of the ‘triangle’ method of ImageJ.  The overlap 
coefficient was determined as the proportion of above-threshold pixels in the green channel that 
were also detected in the red channel, which quantified MBP signals co-localizing with NF200 
signals. An ImageJ plugin was written to fully automate the above steps. MBP+ oligodendrocytes 
were counted manually. 
Cell counts of Olig2+, MBP+ and Ki67+ cells in mixed glial cultures were performed manually. MBP+ 
areas were determined from the number of above-threshold pixels after applying a small median 
filter (radius = 1.5 pixels), followed by subtracting a background image generated by the ‘subtract 
background’ command of ImageJ (sliding paraboloid option, radius = 100 pixels). For each plate the 
threshold was determined and the same threshold was applied to all analyzed images within each 
experiment. An ImageJ plugin was written to automate the above steps. Plugin codes will be made 
publically available on the Queen’s University Belfast website. 
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Experimental designs and statistical analyses 
In all models, sample sizes were chosen based on studies reported previously. For in vivo studies, 
any animal that reached a pre-defined welfare limit before the analysis time-point was excluded 
from the study. For organotypic brain slice experiments, slice integrity was determined by 
neurofilament 200 staining prior to analysis. Animals and brain slices were randomly assigned to 
experimental groups at the beginning of experiments. For certain in vivo experiments, image 
assessment was blinded by generating randomized file names prior to analysis (see code availability 
section below). Myelination indices (brain slices) and MBP area (glial cultures) were blindly assessed 
by a computer programme and in an identical manner for all files. Datasets were tested for normal 
distribution, variances and statistical significance using unpaired, two-tailed, Student’s t tests for 
parametric data with or without Welch correction, or Mann-Whitney tests for non-parametric data, 
detailed in legends. All statistical analysis and graphing of data were performed using GraphPad 
Prism. 
 
Data and code availability 
The datasets generated during and/or analysed during the current study are available from the 
corresponding author on reasonable request. All randomization and analysis coding can be 
downloaded freely at:  http://tinyurl.com/QUBFitzgeraldGroup-FreeToShare
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Figure 1. Treg are required for efficient OPC differentiation during remyelination 
 
C57BL/6 and Foxp3-DTR mice were treated with diphtheria toxin (DT) to deplete Foxp3+ Treg 
or saline as a control. (a-g) A focal demyelinated lesion was induced with lysolecithin on 
day 0 or (h,i) demyelination was induced by cuprizone feeding. In (f,g) Treg were MACS-
purified from wildtype mice and 106 cells/mouse were injected i.p. in the 24 hr prior to spinal 
cord lesioning of Treg-depleted mice (Foxp3-DTR+DT). For immunohistochemistry, tissues 
were fixed by transcardial perfusion and cryosections were stained for oligodendrocyte (Olig2, 
CC1), proliferation (Ki67) markers and counter-stained with DAPI (blue). Cell numbers were 
manually counted and normalized to lesion area. EM was performed as described in 
methods. 
 
(a) Immunohistochemical analysis of CC1+Olig2+ cells per lesion area of Foxp3-DTR and 
C57BL/6 mice at 14 d.p.l, with n=6 in control and n=5 in Treg-depleted groups. 
(b) Representative images of (a) taken on a Leica DM5500 Epifluorescence microscope 
(scale bar=100 µm) (LFB=Luxol fast blue staining). 
(c) Lesion size of Foxp3-DTR mice +/- DT at 5 d.p.l. n=5 animals per group. 
(d) Olig2+Ki67+ cells per lesion area of Foxp3-DTR mice at 5 d.p.l. n=5 animals per group. 
(e) Electron micrographs showing distribution of remyelinated axons versus unmyelinated 
axons in control or Treg-depleted lesions at 17 d.p.l. Scale bar 5 µm (top) and 1 µm (bottom). 
Fewer axons are remyelinated in Treg-depleted animals than in control animals. Three 
animals per group were analysed (middle panel). Data (right panel) represent mean ± SEM 
from 109 micrographs from 3 mice per group. Two-tailed Mann-Whitney test. 
(f) CC1+Olig2+ cells per lesion area of Foxp3-DTR mice with or without adoptively transferred 
Treg at 14 d.p.l., with pooled n=15 animals in Treg-depleted, n=8 in Treg-depleted/adoptively 
transferred Treg group. 
(g) Representative flow cytometric identification of adoptively transferred Treg in lymph nodes 
of Treg-injected mice from (f) and controls, gated on CD4+ cells.  
(h) Immunohistochemical analysis of CC1+Olig2+ cells per lesion area of the corpus callosum 
at 2 weeks post-cuprizone withdrawal. n=5 animals, data represent analysis of 1-2 regions of 
corpus callosum per animal.  
(i) Representative images of (h) at 10x magnification (Leica DM5500). Top: Black Gold II 
(BG) myelin stain. Bottom: CC1+Olig2+ staining.  
  
Data shown are representative of 4 (a,b), 3 (c,d), 2 (f,g) and 1 (e, h, i) independent biological 
experiments, mean +/- SEM, student’s t-test, unless otherwise indicated. *p<0.05, ***p<0.001. 
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Brain stem slices from P0-P2 mouse pups were cultured with Treg-conditioned media (Treg) or 
control media (control). In (a-c) brain slices were cultured  for 7 days. In (d-f) brain slices were 
first cultured for 14 days prior to 16 hr of demyelination with lysolecithin. After lysolecithin 
removal, slices were cultured with Treg-conditioned media or control medium for an additional 
7 days. In (g-i) brain slices were cultured for an initial 7 days after slicing and then with Treg-
conditioned media or control medium for a further 7 days. Brain slices were stained for axonal 
(NF200) and myelin (MBP) markers. MBP+ cells were manually counted and myelination index 
(myelin and axonal staining overlap, representing axonal ensheathment by myelin) was 
determined using an ImageJ plugin. 
 
(a-c) Analysis of (a) MBP+ cells and (b) myelination index per FOV. (c) Representative images 
taken from z-stacks at 7 d.i.v (scale bar=100 µm). Control n=17 and Treg n=8 fields of view from 
3-4 slices/group, Student’s t test. 
(d-f) Analysis of (d) MBP+ cells and (e) myelination index per FOV. (f) Representative images 
taken from z-stacks (scale bar=100 µm). Control n=10, demyelination n=6, remyelination control 
n=20 and Treg n=32 fields of view from 3-6 slices/group, Mann Whitney test.  
(g-i) Analysis of (g) MBP+ cells and (h) myelination index per FOV. (i) Representative images 
taken from z-stacks (scale bar=100 µm). Control n=11 and Treg n= 13 fields of view from 3-6 
slices/group, Student’s t test. 
 
Data shown are representative of 6 (a-c) and 2 (d-f, g-i) independent experiments, mean +/-
 SEM, *p<0.05, **p<0.01, ***p<0.001. 
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Figure 3: Treg directly enhance oligodendrocyte differentiation and myelination in vitro 
 
(a-f) Mixed glial cells from P2–7 mouse pup cortices were expanded for 7 days in vitro and then 
treated for (a-d) 5 or (e,f) 2 days with 5% Treg-conditioned media or control medium as 
indicated. Cells were stained for oligodendrocyte lineage (Olig2), myelin (MBP) and proliferation 
(Ki67) markers. Cell numbers were manually counted and MBP+ area was calculated with an 
ImageJ plugin. 
 
(a-d) Immunofluorescence analysis of (a) MBP+ cell numbers, (b) percentage area, (c) total 
Olig2+ cell numbers and (d) representative images of cultures analyzed (scale bar=100 µm), 
n=6 wells. 
(e,f) Immunofluorescence analysis of (e) Olig2+Ki67+ cell numbers with (f) representative 
images (scale bar=100 µm), n=6 wells.  
(g,h) Pure OPC were treated with 5% of Treg-conditioned media or control medium and were 
analyzed after 2 days for (g) MBP+ cell numbers. (h) Representative image of OPC cultures 
analyzed (scale bar=50 µm), n=12 fields. 
(i,j) Cultures of pure OPC seeded on DRG neurons were treated with 5% Treg-conditioned 
media or control medium and were analyzed after 4 days for differentiation (CC1+) and 
myelination (MBP+). DAPI staining identifies OPC nuclei. (j) Representative image of co-cultures 
in the presence or absence of Treg-conditioned medium, n=20 fields. Enlarged image scale bar 
= 50 µm. 
 
Data shown are representative of at least 12 (a,b,d), 3 (c,g-j) and 2 (e,f) independent 
experiments, mean +/- SEM, Student’s t-test (cell counts) and Mann-Whitney tests (percentage 
area), **p<0.01, *** p<0.001. 
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Figure 4. CCN3 is produced by Treg and promotes oligodendrocyte differentiation and 
myelination 
 
(a) ELISA quantification of CCN3 in T cell conditioned media, n=4, Mann-Whitney test. 
(b) Western blot analysis of CCN3 in Treg-conditioned medium. Recombinant CCN3 (rCCN3, 
25 ng, R&D Systems) was used as a positive control. Samples were pre-enriched for CCN3 
with heparin beads (GE Healthcare) overnight prior to western blotting.  
(c,d) Mixed glial cells were treated with 5% Treg-conditioned medium, or medium control in the 
presence or absence of anti-CCN3 antibody and analyzed after 5 days for (c) MBP+ cell 
numbers and (d) percentage area, n=6 wells, Student’s t-test (counts) or Mann-Whitney tests 
(percentage area). 
(e) Myelination index of brain stem slices treated with 5% Treg-conditioned media in the 
presence or absence of anti-CCN3 or isotype antibody for 7 days, n=15 fields of view from 3-6 
slices/group, Student’s t-test. 
(f) Mixed glial cells were treated with 5% Treg-conditioned medium, or medium control with or 
without CCN3 depletion and analyzed after 5 days for MBP+ percentage area, n=6 wells, Mann-
Whitney test. 
(g,h) Myelination index and representative images of brain slices treated for 7 days with 5% 
Treg-conditioned medium, or medium control with or without CCN3 depletion as well as eluted 
CCN3, n=3-5 fields of view from 3-4 slices/group, Mann-Whitney and Student’s t tests (scale 
bar=100 µm). 
 
Data shown are representative of at least 4 (a), 2 (b, f-h) and 3 (c-e)  independent experiments, 
mean +/- SEM, *p<0.05, **p<0.01, ***p<0.001. 
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Supplementary Figure 1. continued 
Figure S1. Fresh lesional spinal cord (lysolecithin) and brain (cuprizone) tissue of wildtype, Foxp3-
DTR or Foxp3-eGFP mice was harvested and processed for flow cytometric analysis (a-f), 
immunofluorescence analysis (g-i,k) or mRNA analysis by qPCR and in situ hybridisation (j). 
 
(a-d) Representative images of flow cytometric analysis of (a) CD3+ T cells, (b) CD4+ T cells and 
(c,d) CD3+CD4+Foxp3+ Treg, in lesional spinal cord tissue gated on (a,b) CD45+ cells, (c) 
CD45+CD3+ and (d) CD45+CD3+CD4+ at 3 d.p.l. 
(e) Quantitative immunophenotyping of T cell populations in healthy and lesioned spinal cord 
harvested at 3 d.p.l. and 11 d.p.l., gated on CD45+ cells. n=4 mice per group.  
(f) Representative flow cytometric analysis of Foxp3+ Treg cells in fresh spleen from DT-treated 
C57BL/6 (control) and Foxp3-DTR mice (- Treg) at 14 d.p.l., gated on CD4+ cells. 
(g) Olig2+Ki67+ cells per lesion area of Foxp3-DTR mice at 10 d.p.l. with n=8 animals in control and 
n=7 animals in Treg-depleted group. Student’s t test. 
(h) CC1+Olig2+ cells per lesion area at 10 d.p.l. of mice with Treg depletion restricted to pre-
lesioning phase, with n=3 animals in control and n=4 animals in Treg-depleted group. 
(i) Immunohistochemical analysis of CC1+Olig2+ cells per lesion area of the corpus callosum at 10 
days post-cuprizone withdrawal. n=5 animals for C57BL/6 DT-treated controls, n=4 animals for 
saline-treated Foxp3-DTR controls, n=5 animals for Treg-depleted Foxp3-DTR group; data 
represent analysis of 2-4 regions of corpus callosum per animal.  Student’s t-test used for control 
(C57BL/6) vs. –Treg 
(j) plp1 expression analysis in cerebellar tissue of control and Treg-depleted animals at 14 days 
post-cuprizone withdrawal by qPCR (left panel, normalized to gapdh) and by in situ hybridization in 
corpus callosum (right panel, representative images). n=5 animals (control) and n=6 animals in 
Treg-depleted group. Student’s t test.  
(k) Immunohistochemical analysis of total Olig2+ cells per lesion area in the corpus callosum at 10 
and 14 days post-cuprizone withdrawal. n=6 animals (control), n=4 animals (demyelination and 10 
days control remyelination group), n=5 (all other remyelination groups); data represent analysis of 
2-4 regions of corpus callosum per animal. Student’s t test used for day 14.  
 
Data shown are representative of at least 3 (a-d, f), 2 (e, left panel) or 1 (e, right panel, g-k) 
independent experiments. Mean +/˗ SEM, *p<0.05, ***p<0.001, Mann-Whitney test unless 
otherwise stated. 
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Figure S2. Brain stem slices from P0-P2 mouse pups were cultured in the presence or 
absence of  FACS-purified T cells (a-e, 0-3 d.i.v.) or  Treg-conditioned media (g, 0-7 d.i.v) 
or control medium (control). With the exception of (a), brain slices were fixed and stained 
for axonal (NF200) and myelin (MBP) markers. MBP+ cells were manually counted and 
myelination index (myelin and axonal staining overlap, representing axonal ensheathment 
by myelin) was determined using an ImageJ plugin. 
 
(a) Schematic diagram and 3D image of Foxp3-eGFP+ Treg in organotypic brain slice 
cultures representing z-stack images at 3 d.i.v. (scale bar = 100 µm). 
(b,c) Analysis of (b) MBP+ cells per FOV and (c) myelination index, calculated with a 
customized ImageJ plugin as described in methods. Control n=24 FOV, Treg n=15 FOV 
from 3-6 slices/group, Student’s t-test. 
(d) Representative images of brain slices from (b, c) taken from a z-stack image (scale 
bar = 100 µm). 
(e) Analysis of myelination index calculated with a custom ImageJ plugin. Tconv n=15 
FOV and Treg n=14 FOV from 3-6 slices per group, Mann-Whitney test. 
(f) Representative flow cytometric analysis of non-polarized (NP) T cells and Treg 
activated in RPMI medium for 72 hr followed by reactivation in brain slice medium for 
72 hr. FSC = Forward Scatter. 
(g) Analysis of myelination index calculated with a custom ImageJ plugin. NP n=14 FOV 
and Treg n=15 FOV from 3-6 slices per group, Student’s t-test. 
(h-j) Electron microscopic analysis of control (non-demyelinated) and remyelinating brain 
slices with and without Treg-conditioned medium. One-way ANOVA with Bonferroni  post-
test, n=3 slices/condition. *p<0.05, **p<0.01. 
(k) ELISA of IL-6 in brain slice culture-conditioned media up to day 6 in vitro. n=4. 
 
Data shown are representative of at least 2 (a-e, g) 7 (f) or 1 (h-j) independent 
experiments, mean +/˗ SEM, *p<0.05, **p<0.01, ***p<0.001. 
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Figure S3. Mixed glial cultures were established from P2-7 C57BL/6 pups.  
 
(a) Mixed glial cultures were stained for OPC (Olig2, Ki67), oligodendrocyte (Olig2, MBP), 
astrocyte (GFAP) and microglial (CD11b) markers after 1 week of culture. Nuclei were 
counterstained with DAPI (blue). Left panels depict a stitched image of the well of a 96-well 
plate (stitched images were taken at 10x) (scale bars from left to right panels = 500 µm, 
100 µm, 50 µm).  
(b-f) Mixed glial cells from P2-7 mouse pups were expanded for 7 days in vitro and then 
treated for 5 days with 5% Treg-conditioned medium, medium from non-polarized (NP) 
T cells or control medium (control) as indicated.  
(b, c) Immunofluorescence analysis of MBP+ percentage area and (c) representative 
images, n=6. (scale bar = 100 µm). 
(d) Immunofluorescence analysis of MBP+ area of cultures treated with Treg-conditioned 
media derived from total or naïve CD4+ T cells, n=5. 
(e,f) Immunofluorescence analysis of EthD-1+ cell numbers and (f) representative images, 
n=5. (scale bar = 100 µm). 
 
Data representative of (b) 3 and (d,e) 2 independent experiments, mean +/- SEM, unpaired 
student’s t-test (counts) or Mann-Whitney test (percentage area), * p<0.05, ** p<0.01. 
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Figure S4.  
 
(a) Semi-quantitative proteome profiler analysis of non-polarized (NP)- and Treg-
conditioned media (2 independent batches) compared to cell culture medium only. 
(b) Representative immunofluorescence images of mixed glial cultures stained for 
Olig2+MBP+ cells and analyzed quantitatively in Figure 4 c,d. Green = Olig2, red = MBP, 
(scale bar = 100 µm). 
(c) Schematic diagram of CCN3 depletion and elution from Treg-conditioned media. 
(d) ELISA confirmation of CCN3 depletion from Treg-conditioned media.  
 
Data representative of 1 (a), or at least 3 (b,d) biologically independent experiments. 
  
 
Supplementary movies: Videos of z-stack imaging of representative remyelinating 
organotypic brain slices as described in Figure 2d-f. Movie 1 = control, movie 2 = Treg, 
MBP stained red, NF200 stained green. 
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